Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
NVDA INVESTOR ALERT: Hagens Berman Updates NVIDIA Corporation Securities Class Action Investigation Following CEO Jensen Huang’s Resignation Amid Board Review and Revelations Ahead of January 8, 2027 Lead Plaintiff Deadline
GlobeNewswire, Inc.
SAN FRANCISCO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Hagens Berman, a prominent national trial law firm specializing in securities fraud and shareholder rights, alerts investors in NVIDIA Corporation (NASDAQ: NVDA) to breaking developments surrounding...
Battalion Oil Corporation Announces Third Quarter 2026 Financial and Operating Results
GlobeNewswire, Inc.
HOUSTON, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Battalion Oil Corporation (NYSE American: BATL, “Battalion” or the “Company”) today announced financial and operating results for the third quarter of 2026. Key Q3 2026 Highlights Generated third quarter...
Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress
GlobeNewswire, Inc.
— Following positive NEXICART-2 clinical update, commercial launch preparation continues with commercial site activation activities, strengthened team, and provider and payer engagement — — Interim NEXICART-2 clinical trial results selected for...
Capstone Infrastructure Corporation Reports Third Quarter Results and Declares a Quarterly Dividend
GlobeNewswire, Inc.
Toronto, Ontario, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Capstone Infrastructure Corporation (TSX: CSE.PR.A) (the "Corporation" or "Capstone") today announced and filed its financial results for the third quarter ended September 30, 2026. The...
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Third Quarter 2026 Financial Results and Provide Corporate Update
GlobeNewswire, Inc.
WILMINGTON, Del., Nov. 12, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, “NRx” or “the Company”), a commercial biopharmaceutical company developing medicines that target depression, PTSD and suicidality, today announced that it...
Fluent Announces Third Quarter 2026 Financial Results; Commerce Media Solutions Revenue Doubles and Annual Run Rate Now Exceeds $145 Million
GlobeNewswire, Inc.
Q3 2026 revenue of $53.6 million up 14%; nine months 2026 revenue of $146.9 million Q3 2026 Commerce Media Solutions revenue grew 100% to $37.5 million, representing 70% of consolidated revenue compared to $18.8 million or 40% of consolidated...
APP DEADLINE: ROSEN, HIGHLY RECOGNIZED INVESTOR RIGHTS COUNSEL, Encourages AppLovin Corporation Investors to Secure Counsel Before Important November 16 Deadline in Securities Class Action – APP
GlobeNewswire, Inc.
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AppLovin Corporation (NASDAQ: APP) between February 12, 2026 and August 5, 2026, inclusive (the “Class...
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire, Inc.
Total revenues were $19.0 million for the third quarter of 2026 Emrosi® revenues of $9.0 million increased 84% compared to the third quarter of 2025 Company to hold conference call today at 4:30 p.m. ET SCOTTSDALE, Ariz., Nov. 12, 2026 (GLOBE...
CapRock Roofing Details Commercial Permitting Steps After Palestine Code Update
EIN Presswire
Veteran-owned contractor explains Palestine’s 2021 code adoption, TDLR accessibility registration, and TCEQ stormwater rules for commercial builds.
Candel Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire, Inc.
The Company is in ongoing dialogue with the FDA regarding the submission of a Biologics License Application (BLA) for aglatimagene in prostate cancer.
Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2026 Financial Results
GlobeNewswire, Inc.
FORTIFY, a Phase 1b indication expansion trial of PLN-101095, continues strong enrollment Pliant’s proprietary selective, targeted, integrin-mediated delivery platform demonstrates encouraging initial preclinical results Strengthened leadership...
Equillium Reports Third Quarter 2026 Financial Results and Recent Corporate and Clinical Highlights
GlobeNewswire, Inc.
First participant dosed in Phase 1 clinical trial of EQ504, proof-of-mechanism data expected in Q2 2027 Cash equivalents of $53.3 million as of September 30, 2026; pro forma cash balance of approximately $72.0 million after the net effect of $20...
SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
GlobeNewswire, Inc.
- Topline Primary Endpoint Results of the Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia Following the 80th Event to Report this Month - - 40 Patients Enrolled in Phase 2 Trial of SLS009 in Newly Diagnosed First-Line AML;...
Scribe Therapeutics Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
GlobeNewswire, Inc.
Listed on the Nasdaq Global Market under the ticker symbol “SCTX,” and raised capital to fund the initial clinical development of STX-1150, STX-1200, and STX-1400 Continued enrollment in first-in-human Phase 1 clinical trial of STX-1150, the...
TMC Provides Third Quarter 2026 Corporate Update
GlobeNewswire, Inc.
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- TMC the metals company Inc. (Nasdaq: TMC) (“TMC” or “the Company”), a leading developer of the world’s largest resource of critical metals essential to energy, defense, manufacturing and infrastructure,...
Shimmick Corporation Announces Third Quarter 2026 Results
GlobeNewswire, Inc.
IRVINE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) -- Shimmick Corp. (NASDAQ: SHIM), a leading infrastructure solutions provider in water, electrical and other critical infrastructure construction services, today announced financial results for the...
MacroGenics Reports Third Quarter 2026 Financial Results and Highlights Recent Corporate Progress
GlobeNewswire, Inc.
Completed MGC028 Phase 1 dose escalation; selected lead indication for dose optimization across two dose levels Reported interim results at ESMO in both Phase 1 study of MGC026 in heavily pretreated SCCHN patients and Phase 2 study of lorigerlimab...
CCB SHAREHOLDER NOTICE: Coastal Financial Corporation Investors with Substantial Losses Have Opportunity to Lead the CCV Class Action Lawsuit – Hagens Berman
GlobeNewswire, Inc.
SAN FRANCISCO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Global plaintiffs’ rights law firm Hagens Berman Sobol Shapiro LLP is reminding investors in Coastal Financial Corporation (NASDAQ: CCB) of the upcoming court deadline to seek appointment as lead...
New Rockford Area Betterment Corporation: Building a Thriving Future
Bank of North Dakota
(Published in October 2026) – When a business closes, it’s hard to bring it back.
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lennar Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LEN
GlobeNewswire, Inc.
NEW YORK, Nov. 12, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Lennar Corporation (NYSE: LEN) between February 7, 2025 and October 2,...
Sign up for:
Business Herald Online
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.